pharmaceuticals
pharmaceuticals Articles
Visterra has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
24/7 Wall Street has evaluated three major Dow components in the pharmaceutical industry and presented the bullish and bearish case for each in 2016.
Published:
Last Updated:
PLx Pharma has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
Syndax Pharmaceuticals has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
Exelixis Inc. (NASDAQ: EXEL) was up slightly in Tuesday’s trading session following positive results from a late stage trial. The company announced the presentation of positive data from subgroup...
Published:
Last Updated:
Corvus Pharmaceuticals has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Published:
Last Updated:
Janney Capital has weighed in on biotech company Acceleron Pharma and what its outlook stands to be for the future.
Published:
Last Updated:
Akebia Therapeutics plans on raising capital, according to its most recent proposed public offering.
Published:
Last Updated:
Reata Pharmaceuticals has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
Audentes Therapeutics has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
Bavarian Nordic has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
Collegium Pharmaceutical has filed with the U.S. Securities and Exchange Commission (SEC) regarding a secondary offering valued at $86.25 million.
Published:
Last Updated:
24/7 Wall St. has collected four companies big FDA decisions coming up in the first quarter of 2016 and added some color.
Published:
Last Updated:
Sancilio Pharmaceuticals has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
Valeant Pharmaceuticals watched its shares move lower in Monday’s trading session on a health scare from one of its top executives.
Published:
Last Updated: